We conducted lipidomics analyses of 196 lipid mediators in total bone marrow CML cells and found that levels of prostaglandins, eicosanoids and a docosanoid were decreased in Gdpd3-deficient CML cells compared to WT-CML cells [14]. This evidence concerns the gene GDPD3 and chronic myelogenous leukemia, BCR-ABL1 positive.